BioAge Labs, Inc.
BIOA
$10.60
$0.171.63%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -11.58% | -9.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -11.58% | -9.94% | |||
| Cost of Revenue | 19.38% | -16.69% | |||
| Gross Profit | -24.24% | 17.66% | |||
| SG&A Expenses | -4.11% | 10.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.92% | -10.65% | |||
| Operating Income | -15.60% | 10.72% | |||
| Income Before Tax | -17.27% | 14.22% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -17.27% | 14.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -17.27% | 14.22% | |||
| EBIT | -15.60% | 10.72% | |||
| EBITDA | -15.61% | 10.73% | |||
| EPS Basic | -11.11% | 26.95% | |||
| Normalized Basic EPS | -11.12% | 26.94% | |||
| EPS Diluted | -11.11% | 26.95% | |||
| Normalized Diluted EPS | -11.12% | 26.94% | |||
| Average Basic Shares Outstanding | 5.55% | 17.41% | |||
| Average Diluted Shares Outstanding | 5.55% | 17.41% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||